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Abstract
Background:  Preterm infants need high amounts of calcium and phosphorus for bone
mineralization, which is difficult to obtain with parenteral feeding due to the low solubility of these
salts. The objective of this study was to evaluate the physicochemical compatibility of high
concentrations of calcium associated with organic phosphate and its influence on the stability of
AIO admixtures for neonatal use.
Methods:  Three TPN admixture formulas were prepared in multilayered bags. The calcium
content of the admixtures was adjusted to 0, 46.5 or 93 mg/100 ml in the presence of a fixed
organic phosphate concentration as well as lipids, amino acids, inorganic salts, glucose, vitamins and
oligoelements at pH 5.5. Each admixture was stored at 4°C, 25°C or 37°C and evaluated over a
period of 7 days. The physicochemical stability parameters evaluated were visual aspect, pH,
sterility, osmolality, peroxide formation, precipitation, and the size of lipid globules.
Results: Color alterations occurred from the first day on, and reversible lipid film formation from
the third day of study for the admixtures stored at 25°C and 37°C. According to the parameters
evaluated, the admixtures were stable at 4°C; and none of them presented precipitated particles
due to calcium/phosphate incompatibility or lipid globules larger than 5 m, which is the main
parameter currently used to evaluate lipid emulsion stability. The admixtures maintained low
peroxide levels and osmolarity was appropriate for parenteral administration.
Conclusion: The total calcium and calcium/phosphorus ratios studied appeared not to influence
the physicochemical compatibility and stability of AIO admixtures.
Published: 26 October 2009
Nutrition Journal 2009, 8:51 doi:10.1186/1475-2891-8-51
Received: 4 May 2009
Accepted: 26 October 2009
This article is available from: http://www.nutritionj.com/content/8/1/51
© 2009 Ribeiro et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Nutrition Journal 2009, 8:51 http://www.nutritionj.com/content/8/1/51
Page 2 of 13
(page number not for citation purposes)
Background
Preterm infants, children born before 37 weeks of preg-
nancy, are the major recipients of parenteral nutrition
therapy. This group is frequently intolerant to enteral
feeding due to anatomic and functional immaturity of the
digestive tract, added to other clinical conditions that
affect cardiovascular function in the preterm post-natal
life [1-3]. These patients need a calcium/phosphorus ratio
higher than 1 (42 mg/Kg/d Ca and 36 mg/Kg/d P) in order
to allow bone mineralization. Studies on calcium and
phosphorus retention in neonates propose that 1.7/1 (75
mg/Kg/d Ca and 45 mg/Kg/d P) calcium/phosphorus
ratio is closer to that observed for intra-uterine life, allow-
ing greater retention of these ions [4]. This ratio is difficult
to obtain with parenteral feeding, because the availability
of these ions offer is limited by their salts solubility in the
formulation [5].
The most daunting problem today for pharmaceutical
preparation practices of parenteral nutrition is related to
the day-to-day change of volume and formulation nutri-
ents, due to changing clinical conditions and maturation.
Considering the low volumes used in neonatology, it is a
concern to ensure both physicochemical compatibility
and adequate calcium and phosphorus supply. The com-
patibility depends on factors such as solution pH, temper-
ature, material of the parenteral nutrition container,
oxygen, light exposure, composition of trace elements,
presence of vitamins, peroxidation, relative concentration
of each ion, and order of addition of divalent ions such as
calcium [6,7].
Elevated concentrations of cationic electrolytes such as
calcium also interfere in the total parenteral nutrition
(TPN) admixture stability and may influence directly the
size of lipid globules, contributing to the formation of
unstable phases in the lipid emulsion (LE) such as aggre-
gation, flotation, coalescence and phase separation [8].
The main parameter currently used to evaluate lipid emul-
sion physicochemical stability is the percentage of parti-
cles larger than 5 m. According to pharmacopeia
specifications, this should not exceed a total of 0.05% of
lipid globules in the admixture [9,10]. Lipid globules of
this size may clog the pulmonary capillaries, producing an
embolic syndrome and causing cell death mainly in pre-
term infants [11,12]. In addition, an incompatibility
between calcium and phosphorus parenteral salts, form-
ing an insoluble dibasic calcium phosphate precipitate,
may similarly produce a potentially fatal respiratory arrest
[13].
Organic phosphate was introduced on the pharmaceutical
market about two decades ago, and was immediately
approved in some European countries. Due to the high
cost, its use was restricted to patients such as preterm
infants who needed high calcium and phosphorus con-
centrations [14]. The use of organic phosphate in TPN is
not permitted in the United States [15], so compatibility
and stability studies on the TPN admixture in this country
are exclusively associated with preparations containing
inorganic phosphate [16].
Since the introduction of organic phosphate on the mar-
ket, some authors have shown, in clinical comparative
studies, the benefits of the use of organic phosphate in
relation to inorganic phosphate [4,17,18]. However, there
are divergences concerning the utilization of this product,
mainly in regard to the physicochemical TPN admixture
compatibility with high calcium levels, as well as bioavail-
ability. In addition there is still the possible interference of
high calcium concentrations, which may also affect the
emulsion stability.
Due to the clinical relevance of compatibility with high
calcium and organic phosphate concentrations and emul-
sion stability issues posed by the action of calcium and
other cationic electrolytes upon negatively charged lipid
droplets, this paper was aimed at evaluating these factors
in neonatal all-in-one admixtures. The goal was to attain
a higher safety level for these preparations and safe con-
centrations in TPN admixtures.
Methods
Preparation of the admixtures studied
Three TPN admixture formulas for neonatal use were pre-
pared aseptically in a 300-ml 3-layered bag composed by
polyester, polypropylene and polyethylene (HalexIstar,
Goiânia, Brazil) under a laminar-flow hood in accordance
with the National Health Department specifications Nr.
272 (1988), designed for infusion through central access.
The TPN admixture formulas were prepared with market
products from pharmaceutical industries and based on
official regulations [13,16,19].
Experimental Procedures
Each admixture was prepared separately in triplicate or
quadruplicate (referred to as 3 or 4 lots) divided into three
groups and stored at different temperatures: 4°C ± 2°C, in
refrigerator; 25°C ± 3°C, simulating room temperature;
and in an incubator at 37°C ± 2°C, simulating an infu-
sion temperature in a worst-case scenario. A different
number of samples were tested from each of the lots
depending on the technique applied. The experiments
were performed on the day of the TPN admixture prepara-
tion and also 24 h, 48 h, 72 h and 7 days after preparation,
time periods indicated as D0, D1, D2, D3 and D7, respec-
tively.
Samples for the sterility test and for the physicochemical
tests were aseptically collected from each formulation atNutrition Journal 2009, 8:51 http://www.nutritionj.com/content/8/1/51
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appropriate intervals using a plastic syringe. The physico-
chemical compatibility and stability parameters evaluated
were general visual aspect, presence of dibasic calcium
phosphate precipitation, pH, sterility, osmolarity, perox-
ide formation, and the size of lipid globules.
Sterility test
The maintenance of the TPN admixture sterility was eval-
uated using a biphasic culture medium, which contains a
liquid phase composed of sterile soybean casein broth
and a solid phase composed of sterile soybean casein agar
(TSA/TSB). This culture medium promotes growth of non-
specific aerobic microorganisms and is used in accordance
with recommendations of USP 31, chapter 71 [19,20].
The analysis is based on inoculation of a TPN admixture
sample (2 ml) in a flask containing the biphasic culture
medium at the end of the manipulation of each bag. This
flask was immediately stored after inoculation in an oven
at 30°C ± 2°C for a 14-day period. At intervals (24 h) dur-
ing the incubation period, the media were examined for
macroscopic evidence of microbial growth in the solid
phase. If no evidence of microbial growth was found after
14 days the product complies with the test for sterility.
This procedure was carried out in all admixture lots.
Physicochemical assessments
On visual inspection, parameters that evidence instability
and incompatibility events were examined. Color change,
precipitation, film formation and phase separation were
sought. The color change assay was not graduated;
instead, a positive response was registered when darken-
ing occurred. Precipitation was evaluated visually and
microscopically by observing formation of rigid crystal-
line structures. The stability of the emulsion, on a visual
basis, was assessed by the observation of a yellow fat layer
on the top of the admixture, referred to as film formation
(creaming). The film thickness was measured using a ruler
with millimeter precision. Phase separation was recorded
when two different phases could be observed. The visual
inspection was performed in all the admixtures during the
seven days of study at all temperatures and was registered
through digital photography.
For the evaluation of pH, a Mettler Toledo potentiometer
calibrated with pH 4 and pH 7 buffers was used. For each
measurement, a 10 ml sample was collected and placed in
an amber glass flask. The pH was measured by dipping the
electrode directly into the emulsion, at room temperature.
The visual inspection and pH determination were carried
out each day in quadruplicate for each formulation in all
the conditions studied.
The osmolalities were measured experimentally using a
Wescor micro-osmometer. The TPN admixture osmolali-
ties is determined through its freezing point. Before each
measurement session, the equipment was calibrated with
standard solutions of 100, 290 and 1000 mOsm/Kg H2O,
composed of NaCl and preservative in water. The equip-
ment range is from 0 to 3000 mOsm/Kg H2O. The osmo-
lality (mOsm/Kg H2O) was converted into osmolarity
(mOsm/l H2O) using the density of the TPN admixtures
measured with a pycnometer. The mean density of the
admixtures studied was 1.04 g/ml at 25°C. The osmolar-
ity of the TPN admixtures was estimated by multiplying
the measured osmolality by the TPN admixture density
and subtracting the concentration (g/ml) of the solutes
present in the emulsion, according to Martin et al [20].
The concentration of the solutes calculated for the TPN
admixture was 0.2 g/ml at the highest concentration of
calcium. The measurements were carried out on three dif-
ferent lots on day 0 for each formulation at each temper-
ature condition.
Globule size measurement
The size of the lipid globules was measured with an Axio-
plan 2 optical microscope (Carl Zeiss, Germany) using a
digital camera connected to a computer and a television
set, at a total magnification of 1000×. This combination
makes it possible to measure globules as small as 0.2 m.
A 5-ml sample of TPN admixture was collected from the
bag with a sterile syringe and placed in a sterile vacutainer.
From this vacutainer, a 20-l sample was collected and
diluted 1:4 using its own admixture but without lipids.
From this dilution, a 6-l sample was transferred to a slide
with an automatic pipette and then an 18 × 18 mm cover
slip was laid over it. Initially different fields were exam-
ined to investigate incompatibility based on the presence
of dibasic calcium phosphate crystals in the sample. When
crystals were not found, evaluation of the lipid globule
stability was initiated. Between 1000 and 1500 lipid glob-
ules per field were observed and counted in each of two
fields in each admixture sample. The measurement was
carried out with two different lots of each formulation for
each of the studied conditions. For each lot, images of
three randomly chosen fields were registered for posterior
analysis by the software. Results are presented in the figure
as a representative field from a set of three collected from
each of two different lots, on different days. The globules
are grouped according to size range: 0-1 m; 1-2 m; 2-3
m and > 3 m, and the percentage in each range are cal-
culated in relation to the total number of measured glob-
ules. Maximum globule diameter was also recorded.
The images were collected and kept for further analysis.
The images were treated with the AnalySIS software (Soft
Imaging System, Münster, Germany), which converts the
images into gray scales and then into a black and white
binary system, allowing the identification and counting of
the lipid globules.Nutrition Journal 2009, 8:51 http://www.nutritionj.com/content/8/1/51
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Peroxide formation
Lipid hydroperoxide and hydrogen peroxide were quanti-
fied by evaluating the oxidation of iron in a xylenol
orange solution (Spectrum, New York, USA), modified for
use with lipids according to the FOX 2 method previously
described [21,22]. The method is based on the reaction of
2-thiobarbituric acid (TBA) with aldehydes formed by oxi-
dized lipids in acid medium. The reaction is processed
after 30 min, followed by centrifugation. This reaction
forms a red-colored product, which is read at a wavelength
of 560 nm in a Shimadzu model UV 2401PC spectropho-
tometer. It was tested all the admixtures through this
methodology over a period of seven days at the tempera-
tures of 4°C and 37°C totally photo protected (dark
room), 25°C exposed to indirect artificial light, including
the admixtures contained in bags photo protected at
25°C.
The peroxide concentration in the admixture samples was
calculated from a hydrogen peroxide standard curve, in
the range of 1 a 100 M, prepared at the same day
[21,23,24]. The experiments were carried out with 3 dif-
ferent lots (i.e. in triplicate).
Statistical treatment
The results are expressed as mean and standard deviation.
The graphical displays were created on SigmaPlot 10.0
(SPSS, Erkrath, Germany). The experimental results were
analyzed for significance using Student's t test at P < 0.05.
Results
Table 1 presents the three formulas, PC, P1 and P2,
designed for this study. The TPN formulas differ in cal-
cium content. The calcium/phosphorus ratios for P1 and
P2 admixtures are (calcium and phosphorus) 2/1 and 4/
1, respectively, and the control parenteral nutrition (PC)
is free of calcium. Thus the calcium content of the admix-
tures was different in each formula, while the organic
phosphate content was the same in the concomitant pres-
ence of vitamins and trace elements. All the nutrients were
mixed in the same bag, always following the order pre-
sented at Table 1. The compatibility and stability of the
admixtures were assessed.
The following parameters were evaluated through visual
inspection: color alterations, precipitation, film forma-
tion, and phase separation, for the three admixtures stud-
ied over a period of seven days at temperatures of 25°C,
4°C and 37°C, as demonstrated in Table 2. After 24 h at
Table 1: Formulations used in the study
Insumes Daily allowance PC P1 P2
Total volume 100-150 mL/kg/d 100 ml 100 ml 100 ml
Pediatric amino acid with taurine 10% 1-3 g/kg/d 3 g 3 g 3 g
Multivitamin A- 1.38 mg/d 0.128 mg 0.128 mg 0.128 mg
D- 6.25 g/d 0.5 g 0.5 g 0.5 g
E- 1.67 mg/d 1.0 mg 1.0 mg 1.0 mg
B1- 11.25 mg/d 0.3 mg 0.3 mg 0.3 mg
B2- 2.5 mg/d 0.36 mg 0.36 mg 0.36 mg
B3- 25 mg/d 4.0 mg 4.0 mg 4.0 mg
B5- 6.5 mg/d 1.5 mg 1.5 mg 1.5 mg
B6- 3.0 mg/d 0.4 mg 0.4 mg 0.4 mg
B7- -- 6.0 g 6.0 g 6.0 g
B9- 200 g/d 40 g4 0   g 40 g
B12- 3.0 g/d 0.5 g 0.5 g 0.5 g
C- 250 mg/d 10 mg 10 mg 10 mg
Glucose 50% 4-12 mg/kg/min 8.64 g 8.64 mg 8.64 mg
Pediatric element + zinc acetate Zn- 400 g/kg/d 350 g3 5 0   g3 5 0   g
Cu- 20 g/kg/d 20 g2 0   g 20 g
Cr- 0.2 g/kg/d 0.2 g 0.2 g 0.2 g
Mn-1.0 g/kg/d 2.0 g 2.0 g 2.0 g
NaCl* 20% 3-5 mEq/kg/d 4 mEq 4 mEq 4 mEq
Sodium glycerophosphate 1-2 mEq/kg/d 1.1 mEq 1.1 mEq 1.1 mEq
KCl* 10% 2-3 mEq/kg/d 2 mEq 2 mEq 2 mEq
Calcium gluconate 200-800 mg/kg/d 0 500 mg 1000 mg
Calcium 18.6-37.2 mg/kg/d Ca 0 46.5 mg 93.0 mg
Magnesium sulphate 0.25-0.5 mEq/kg/d 0.25 mEq 0.25 mEq 0.25 mEq
Lipid emulsion 20% MCT/LCT* 1-3 g/kg/d 2 g 2 g 2 g
MCT/LCT- medium- and long-chain triglycerides; NaCl - sodium chloride; KCl -potassium chloride; Zn-Zinc; Cu-Copper; Cr-Chromium; Mn-
Manganese; A-Retinol; D-Cholecalciferol; E-Tocopherol; B1-Thiamine; B2-Riboflavin; B3-Nicotinamide; B5-Pantothenic acid; B6-Pyridoxine; B7-Biotin; 
B9-Folic acid; B12-Cyanocobalamin; C-Ascorbic acid.Nutrition Journal 2009, 8:51 http://www.nutritionj.com/content/8/1/51
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temperatures of 25°C and 37°C, color alteration was
observed in all the formulations. On the other hand, there
was no color alteration at any time for admixtures at 4°C.
No precipitation due to incompatibility was observed in
any of the admixtures. The formation of a film layer, the
first step in a phase separation process, was observed only
after 72 h and only for admixtures maintained at 25°C
and 37°C. It is worth emphasizing that formation of this
film was easily reversed with a smooth shake. No phase
separation was observed in any of the admixtures.
There were no colonies forming units (CFUs) on the solid
phase in the culture medium after fourteen days of incu-
bation in an oven at 30°C. The absence of CFUs in the
biphasic culture medium demonstrates the maintenance
of the admixtures' sterility.
The mean and standard deviation of pH values for TPN
admixtures during the seven days of study, at the three dif-
ferent temperatures selected. In all cases the pH remained
around 5.5 throughout the study period and showed no
significant differences between the values of D7 and D0 in
each condition tested. P2 admixture presented a initial pH
of 5.57 ± 0,32; after seven days of storage at 25°C, 4°C
and 37°C the values measured were: 5.53 ± 0.28, 5.51 ±
0.36 and 5.52 ± 0.30, respectively. Similar values were
measured for PC and P1.
The osmolarity values for TPN admixtures are presented
in Table 3. The results are presented separately according
to temperature, since each TPN admixture corresponds to
a different lot. The mean values showed no significant dif-
ferences with temperature, also demonstrating homoge-
neity among the lots.
The presence of particles in the admixtures was evaluated
by optical microscopy (OM). Particles are easily recog-
nized due to the rigid crystalline structure of the precipi-
Table 2: Visual inspection of TPN admixtures
Parameters PC P1 P2
25°C
D 0 *D 1D 2D 3D 7D 0D 1D 2D 3D 7D 0D 1D 2D 3D 7
Color alteration A PPPPA PPPPA PPPP
P r e c i p i t a t i o n A AAAAAAAAAAAAAA
Film formation A A A PPAAPPPAAAPP
P h a s e  s e p a r a t i o n A AAAAAAAAAAAAAA
4°C
D0 D1 D2 D3 D7 D0 D1 D2 D3 D7 D0 D1 D2 D3 D7
C o l o r  a l t e r a t i o n A AAAAAAAAAAAAAA
P r e c i p i t a t i o n A AAAAAAAAAAAAAA
F i l m  f o r m a t i o n A AAAAAAAAAAAAAA
P h a s e  s e p a r a t i o n A AAAAAAAAAAAAAA
37°C
D0 D1 D2 D3 D7 D0 D1 D2 D3 D7 D0 D1 D2 D3 D7
Color alteration A PPPPA PPPPA PPPP
P r e c i p i t a t i o n A AAAAAAAAAAAAAA
Film formation A A A PPAAAPPAAAPP
P h a s e  s e p a r a t i o n A AAAAAAAAAAAAAA
*D: day, A: absence, P: presence; n = 4 lots.
Table 3: Values of the experimental osmolarity for TPN 
admixtures at the three temperatures selected
Experimental Osmolarity (mOsm/L)
25°C 4°C 37°C
PC 848 ± 8.7* 791 ± 2.4 792 ± 8.0
P1 791 ± 7.0 772 ± 1.8 805 ± 17
P2 831 ± 13 865 ± 14 836 ± 54
Mean ± standard deviation, n = 3 lots, measured on D0.Nutrition Journal 2009, 8:51 http://www.nutritionj.com/content/8/1/51
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tates. No evidence of precipitation was observed in the
admixtures under any of the conditions studied.
Among parameters obtained through OM, the one
selected to evaluate the admixtures' stability was the
diameter of the lipid globules. This parameter provides an
index of the size of the lipid globules, making it possible
to monitor size changes due to temperature and type of
admixture over time. Figure 1 represents the mean diame-
ter of the lipid globules over the seven days; maximum
values are shown in Table 4, demonstrating that no glob-
ules greater than 4 m were formed.
Table 4 serves to emphasize that occasionally a larger lipid
globule could be found, regardless of the day of analysis,
as for example in D0, where there is a 4 m lipid globule
in admixture P2.
Figure 2 shows the distribution of globule size range in
percent of total number of globules measured under each
condition on days 0 and 7. None of the lipid globules
exceeded 4 m in any of the admixtures during the seven
days of analysis at any temperature, even in the presence
of high amounts of calcium.
Other optical microscopy parameters related to stability
such as Ferret diameter, area, sphericity, perimeter, convex
perimeter, format factor and stretching were measured.
There was no significant alteration in any of these param-
eters for any of the admixtures with time or temperature.
PC, P1 and P2 admixtures were tested for peroxide at days
D0, D1, D2, D3 and D7. The concentrations of peroxide
formed in each admixture over a period of seven days at
each temperature are presented in Figure 3. The formula-
tions stored at 4°C and 37°C were kept in total absence of
light and stored at 25°C with artificial room light expo-
sure and with photo-protection. Statistical analysis of val-
ues obtained at D0 and D7 revealed a significant increase
(P < 0.05) in the P1 stored at 25°C (Figure 3A), in PC and
P1 at 4°C (Figure 3B) and in P1 at 37°C (Figure 3C). The
peroxide values in admixtures with photo protection stud-
ied at 25°C on days D0 were: 1.5, 2.5 and 3.7 M, on day
D1: 4.8, 4.8 and 3.5 M, on day D3: 5.5, 5.10 and 5.3 M
and on day D7: 7.8, 7.7 and 5.2 M, respectively for PC,
P1 and P2 admixtures. The values obtained with photo
protection are lower than those observed at the same tem-
perature, under artificial room light exposure (Figure 3A);
but increased compared with the admixtures kept at 4°C
totally photo protected (cf. Figure 3B).
Discussion
The TPN admixtures prepared with 2/1 and 4/1 of cal-
cium/phosphorus ratios were free of crystal formation,
showing physicochemical compatibility during seven
days of storage. Thus, no evidence of incompatibility
between calcium and organic phosphorus was observed.
It is recommended for preterm an intravenous adminis-
tration of 200 to 800 mg/kg/day of calcium gluconate and
47 to 70 mg/kg/day of phosphate, concentrations closer
to that observed in the uterus. These quantities are diffi-
cult to be obtained using the inorganic source due to the
low solubility of these ions in aqueous solution [5,25]. In
order to maintain the biochemical and hormonal home-
ostasis and a suitable bone mineralization in preterm
infants, the calcium/phosphorus ratio must be greater
than 1. The inversion of this ratio can cause an increase in
the secretion of parathormone, which leads to loss of
phosphate in urine and osteopenia [5].
Clinical research has been showing the advantages in
bone mineralization using organic phosphorus [4,18,26-
28]. However, in addition to the concern of offering a
clinical efficient TPN admixture, the physicochemical the
stability of these formulations need to be considered and
has been discussed [16,29,30]. Thus, in this work formu-
lations were prepared varying the amount of calcium with
fixed amount of phosphate to test the stability of organic
phosphorus in the presence of high concentrations of cal-
cium in admixtures containing lipid, vitamins and trace
elements. Despite the TPN form a lipid emulsion, which
may be subject to a process of physical instability, several
metabolic benefits are associated with the administration
of TPN admixtures over 2 in 1, such as the prevention of
hyperglycemia and the essential fatty acids lack, less
Table 4: Maximum lipid globule size diameter
Temperature (°C) Maximum diameter (m)
D0 D1 D2 D3 D7
PC
25 2.2 2.7 3.5 2.2 1.3
4 2.6 2.1 1.9 2.1 2.4
37 1.9 2.4 2.7 2.9 2.6
P1
25 2.3 1.9 2.3 1.6 3.8
4 2.4 2.9 2 1.5 1.8
37 2.1 1.6 2.2 1.8 3.1
P2
25 3.7 3 1.6 2.3 1.8
4 3.1 2.4 2.8 1.9 2
37 4 2.8 2.6 2.5 2.2
n = 2 lots for each condition at each time.
D0, D1, D2, D3 and D7 represents the day of the TPN admixture 
preparation and 24 h, 48 h, 72 h and 7 days after preparation, 
respectively.Nutrition Journal 2009, 8:51 http://www.nutritionj.com/content/8/1/51
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Number of globules counted for each bar, use of OM Figure 1
Number of globules counted for each bar, use of OM. Bar graphs represent the mean and standard deviation of the 
diameter of lipid globules present in admixtures PC, P1 and P2 stored at 25°C, 4°C and 37°C, during seven days of study D0 - 
D7 (n = 2 lots).Nutrition Journal 2009, 8:51 http://www.nutritionj.com/content/8/1/51
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Percentage of lipid globules in relation to total number of globules examined, distributed by size range Figure 2
Percentage of lipid globules in relation to total number of globules examined, distributed by size range. Bar 
graphs represent the mean percentage of lipid globules in each range present in admixtures PC, P1 and P2 stored at 25°C, 4°C 
and 37°C after 0 and seven days of study (n = 2 lots).Nutrition Journal 2009, 8:51 http://www.nutritionj.com/content/8/1/51
Page 9 of 13
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Peroxide formation in the admixtures Figure 3
Peroxide formation in the admixtures. Bar graphs represent the mean and standard deviation of the peroxide (TBARS) 
formed in admixtures PC, P1 and P2 stored at 25°C, 4°C and 37°C during seven days of study D0 - D7 (n = 3 lots; *P < 0.05, 
D7 compared with D0).Nutrition Journal 2009, 8:51 http://www.nutritionj.com/content/8/1/51
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manipulation in the infusion line and a lower osmolarity
of the final emulsion.
The physical stability of the lipid emulsions can be
improved by using surfactants that form a coalescence
energy barrier that carries electric charges around the dis-
persed liquid, aiming at decreasing the surface tension
and increasing the repulsion force between the dispersed
liquids [31]. In the case of TPN admixtures containing egg
lecithin as anionic emulsifier, the lecithin produces a neg-
ative charge around the lipid globules through the ioniza-
tion of the phosphate groups. Any positively charged ion,
such as calcium, could cause irreversible instability in this
system, neutralizing the negative phospholipids droplets
and promoting coalescence [8].
Therefore, the pH of the final admixture is important as a
factor that directly influences the ionization of the lipid
globule phospholipids, and also interferes in the dissoci-
ation of ions in solution. Many factors determine the final
pH of the TPN admixture [9], as composition, final con-
centration of the amino acids, type and final concentra-
tion of the phosphate, cysteine addition, peroxidation
and final glucose concentration. The pH for pediatric TPN
admixtures ranges from 5.0 to 6.0, and the admixtures
contain high concentration of amino acids such as HCl
cysteine, histidine and arginine, as well as a high concen-
tration of glucose [16,32]. The pH of the admixtures stud-
ied remained within this range with no significant
alterations over time, showing that the high calcium/
phosphorus ratio in the admixture and the temperature of
storage had no adverse effect on pH.
Among some of the clinical disorders associated with the
parenteral infusion of an unstable lipid emulsion the pro-
duction of hepatic accumulation of fat associated with
oxidative stress, liver injury, and a low-level systemic
inflammatory response can be mentioned [33]. In this
work it the stability of TPN admixtures with a high con-
centration of divalent ions was studied. The maximum
globule size observed, shown in Table 4, represents a van-
ishingly small percentage when compared to the total
numbers of globules measured, which is the reason
because a percentage of this range cannot be visualized in
Figure 2. The values observed were well below the recom-
mended limit; however, the increased globules could
occur sporadically, that is why it would be important to
connect filters in line with the infusion equipment in
order to ensure uniformity in the size of the lipid globules
infused in these preterm infants. The TPN 1.2-m filters
significantly reduce the total number and concentration
of enlarged fat globules and effectively remove rigid crys-
talline particulates [34]. The other size parameters quanti-
fied through OM showed a profile similar to the mean
diameter, with no significant alteration during the study.
OM is a recognized technique for the qualitative evalua-
tion of TPN admixture stability and its profile, since many
randomly selected fields can be considered in the analysis.
However, it fails to predict the quantitative evaluation of
the lipid stability (PFAT5) of the admixtures overall due
the small amount of sample employed in the OM analy-
ses. So, these results need to be considered within the lim-
itations of the technique and require confirmation by
light obscuration.
Visual inspection is a simple method to evaluate the LE
physicochemical compatibility, but extremely important.
Color alteration, presence of precipitate and instability
phases were evaluated in this step and confirmed micro-
scopically. Color alteration in TPN is well known due to
the Maillard reaction and oxidation of some vitamins
[6,14]. It is undesirable because it may represent a loss of
bioavailability, due loss of some nutrient [5]. In the
present study the color alteration that occurred was unre-
lated to the concentration of calcium, since the PC admix-
ture (without calcium) showed the same change as P2.
Color alteration was observed in admixtures stored at
25°C and 37°C, but no alteration was observed when
stored at 4°C. Color alteration is related not only to tem-
perature, but also to light, which is the reason for the great
difference in color between bags kept at 25°C, in room
temperature, and at 4°C, in the refrigerator. In the bag
stored at 25°C with photo protection, no color alteration
was observed during the days of study (data not shown).
Although the infusion of parenteral admixture must be at
room temperature, these results indicate that the ideal
storage condition is at 4°C, with photo protection, regard-
less of calcium. The data suggest that the admixtures
should not be kept for a long period at 25°C before use,
and that equipment with photo protection should be
used.
The maintenance of the sterility of the admixtures studied
in this paper was fundamental for us to attribute the alter-
ations to possible incompatibility or lipid emulsion insta-
bility events due to the high calcium concentration, and
not to changes caused by microbiological contamination.
In neonatology, for central access, the osmolarity level
must be kept at around 800 mOsm/L, not exceeding twice
the regular serum osmolarity [30,35]. High osmolarity
arises from high ion concentrations as well as glucose, and
the ionic components may also affect the lipid globule
stabilization. In this study, the experimental osmolarities
were kept within the recommended range for the central
access administration of the admixtures studied; and as
expected, no significant differences in osmolarities were
observed at different temperatures.Nutrition Journal 2009, 8:51 http://www.nutritionj.com/content/8/1/51
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The infusion of oxidized lipids and secondary peroxida-
tion products can be extremely cytotoxic, and may cause
many disorders, such as hepatic steatosis [36], hyper trig-
lyceridemia [37], increase in vascular resistance in the
lung [17,38], lung remodeling [39] and chronic lung dis-
eases of prematurity [40,41]. TPN is a potential source of
oxidants and this is particularly dangerous in preterm
infants who are vulnerable to oxidative stress [42,43]. The
peroxide formation caused by exposing TPN admixtures
to phototherapy is well-known in the neonatology field
[23,44,45]. This is corroborated by the demonstration
that physical protection of the light incidence in TPN
admixtures leads to formation of even lower concentra-
tions of peroxides than the usual photo protection
[23,45].
The objective of this study was to evaluate the stability of
the formulations with high calcium/phosphorus ratio, so
experiments were performed varying only the temperature
of storage without light exposure. Despite the fact that all
peroxide values measured were very low (Figure 3), the
admixtures kept photo-protected and totally in absence of
light, presented even lower peroxide values, different from
those observed in Figure 3A. This observation reinforces
the necessity of photo protection for the TPN admixture
infusion equipment.
The calcium and phosphorus presence even at high con-
centrations did not show a statistically significant change
in the peroxides value when compared with the control
formulation. Low values of peroxide were measured, com-
parable to values previously demonstrated by other
authors when the formulation was totally photo protected
[23,45]. The low peroxide value observed could be attrib-
uted to many favorable factors, such as the multilayered
bag used to store the formulations [42,46]. It has been
shown that TPN admixtures in multilayered bag present
less oxidation evaluated by hydroperoxide formation
[46,47]. This bag has low oxygen permeation and could
be collapsed to eliminate, as much as possible, the oxygen
in the bag. Moreover, the presence of amino acids [42,48]
in formulations containing trace elements, lipids and vita-
mins [23] decrease the peroxide formation and its clinical
complications [39,42]. Lavoie et al [42] showed that dur-
ing the 6 hours after TPN preparation the balance between
generation and consumption of peroxides is positive, and
after this time they presume that the balance changed in
favor of the consumption, during their transformation
into free radicals via the Fenton-like reaction induced by
trace elements present in the PN solution [49].
Although it was shown that the vitamin solutions cause
more peroxidation [36,41,42], some vitamins have been
shown to have antioxidant effects, as vitamin C
[23,39,45,50]. The oxidation of aminoacids and vitamin
C could prevent the lipid peroxidation turning the perox-
idation undetectable. When the amino acid oxidizes the
formulation becomes darkened, as observed in admix-
tures stored at 25°C exposed to artificial light. The relative
protective effect of amino acid in the peroxidation in the
presence of vitamins and light for 24 hours was already
demonstrated [42].
Antioxidant activity of trace elements is demonstrable in
some constituents as selenium and copper [51,52]. How-
ever, by evaluation of peroxide in the urine in preterm
infants, it was observed that the use of trace elements did
not affect peroxide production [41]. Even though, Steger
et al [53] had shown by in vitro studies the increase in per-
oxidation in TPN admixtures associated with trace ele-
ments, these results may be due to the long period of
analysis up to 30 days [53].
Conclusion
In conclusion, we have demonstrated that, according to
the parameters evaluated, the high calcium/phosphorus
concentration was compatible. The AIO admixtures stud-
ied were physicochemical stable. The three admixtures
maintained low peroxide levels. There was no significant
pH alteration during the study period. The preliminary
results suggest that the admixtures studied did not have
abnormal particle or globule counts, and thus, were com-
patible and stable by OM, but the fact that visual changes
were noted in the color and the extent of the lipid film for-
mation in the admixtures stored at 25°C or 37°C may
suggest otherwise. As our data are preliminary with regard
to particle or globule size analysis in neonatal AIOs, they
will require confirmation that by light obscuration to con-
firm these admixtures are indeed compatible and stable,
and thus safe for parenteral administration.
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